There are new and innovative methods to better understand the risk factors for and improve earlier detection of pancreatic cancer. Specifically, researchers can demonstrate that the development of, new biomarkers, novel treatment targets, innovative approaches to screening and surveillance and improved understanding of risk factors can lead to diagnosis of pancreatic cancer at earlier more treatable stages.